Scary science: Ondansetron safety in pregnancy-two opposing results from the same danish registry

Gideon Koren

doi:10.1097/FTD.0000000000000020

Scary science: Ondansetron safety in pregnancy-two opposing results from the same danish registry

Gideon Koren

نتاج البحث: نشر في مجلة › مقالة مرجعية › مراجعة النظراء

11 اقتباسات (Scopus)

ملخص

While perceived safe in pregnancy, several recent studies raise concerns about both fetal and maternal safety of ondansetron. Until more data are available, it should not be a first-line medication for morning sickness.

اللغة الأصلية	الإنجليزيّة
الصفحات (من إلى)	1-2
عدد الصفحات	2
دورية	Therapeutic Drug Monitoring
مستوى الصوت	36
رقم الإصدار	1
المعرِّفات الرقمية للأشياء	https://doi.org/10.1097/FTD.0000000000000020
حالة النشر	نُشِر - فبراير 2014
منشور خارجيًا	نعم

الوصول إلى المستند

10.1097/FTD.0000000000000020

الملفات والروابط الأخرى

Link to publication in Scopus

قم بذكر هذا

@article{1da079e67d2e4a69a5f5a2c016eb1b48,

title = "Scary science: Ondansetron safety in pregnancy-two opposing results from the same danish registry",

abstract = "While perceived safe in pregnancy, several recent studies raise concerns about both fetal and maternal safety of ondansetron. Until more data are available, it should not be a first-line medication for morning sickness.",

author = "Gideon Koren",

year = "2014",

month = feb,

doi = "10.1097/FTD.0000000000000020",

language = "אנגלית",

volume = "36",

pages = "1--2",

journal = "Therapeutic Drug Monitoring",

issn = "0163-4356",

publisher = "Lippincott Williams and Wilkins",

number = "1",

}

TY - JOUR

T1 - Scary science

T2 - Ondansetron safety in pregnancy-two opposing results from the same danish registry

AU - Koren, Gideon

PY - 2014/2

Y1 - 2014/2

N2 - While perceived safe in pregnancy, several recent studies raise concerns about both fetal and maternal safety of ondansetron. Until more data are available, it should not be a first-line medication for morning sickness.

AB - While perceived safe in pregnancy, several recent studies raise concerns about both fetal and maternal safety of ondansetron. Until more data are available, it should not be a first-line medication for morning sickness.

UR - https://www.scopus.com/pages/publications/84892913741

U2 - 10.1097/FTD.0000000000000020

DO - 10.1097/FTD.0000000000000020

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.systematicreview???

AN - SCOPUS:84892913741

SN - 0163-4356

VL - 36

SP - 1

EP - 2

JO - Therapeutic Drug Monitoring

JF - Therapeutic Drug Monitoring

IS - 1

ER -

Scary science: Ondansetron safety in pregnancy-two opposing results from the same danish registry

ملخص

الوصول إلى المستند

الملفات والروابط الأخرى

بصمة

قم بذكر هذا